Forsström J
Medical Informatics Research Centre, University of Turku, Finland.
Int J Med Inform. 1997 Dec;47(3):143-52. doi: 10.1016/s1386-5056(97)00098-1.
Human drugs and medical devices have to be approved by the health authorities before they can enter the market. For medical software this is not needed. The main argument to resist all attempts to regulate medical software has been that it is impossible to guarantee that software is error-free. This is true of all software. However, in medical software the correctness of medical knowledge is at least as important as the correctness of the code itself. The medical contents of the software could usually be evaluated but the end-users do not have the time or possibilities to do so. The Internet makes it possible to provide commercial services designed by non-professionals. For health care, there are already several commercial services on the net. Since there is no quality assurance or regulation of medical software anyone can sell medical software on the net. Even if physicians were cautious enough not to use untested software, there is a possibility that patients do. In Finland, where over 10% of the population is using the Internet at least weekly, the problem is real. It is impossible to remove poor services from the net and therefore, it is essential to guide the users to use high quality services. The paper discusses different aspects of evaluation of medical software.
人类药物和医疗设备在进入市场之前必须经过卫生当局的批准。而医疗软件则无需如此。抵制所有规范医疗软件尝试的主要论点是,无法保证软件没有错误。所有软件都是如此。然而,在医疗软件中,医学知识的正确性至少与代码本身的正确性一样重要。软件的医学内容通常可以评估,但最终用户没有时间或能力这样做。互联网使得提供由非专业人员设计的商业服务成为可能。对于医疗保健领域,网上已经有几种商业服务。由于没有对医疗软件的质量保证或监管,任何人都可以在网上销售医疗软件。即使医生足够谨慎,不使用未经测试的软件,患者仍有可能使用。在芬兰,超过10%的人口至少每周使用一次互联网,这个问题是切实存在的。不可能从网上清除劣质服务,因此,引导用户使用高质量服务至关重要。本文讨论了医疗软件评估的不同方面。